BACKGROUND Elevated resting heart rate is a risk factor for cardio-vascular events.OBJECTIVE The purpose of this study was to investigate the clinical significance of nocturnal heart rate (nHR) and 24-hour mean heart rate (24h-HR) obtained by continuous remote monitoring (RM) of implantable devices.METHODS We analyzed daily-sampled trends of nHR, 24h-HR, and physical activity in patients on b-blocker therapy for chronic heart failure and with implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators (CRT-Ds). Patients were grouped by average nHR and 24h-HR quartile during follow-up to es-timate the respective incidence of nonarrhythmic death and device -treated ventricular tachycardia/fibrillation (VT/VF).RESULTS The study cohort included 1330 patients (median age 69 years [interquartile range 61-77 years]; 41% [n = 550] with CRT-D; median follow-up 25 months [interquartile range 13-42 months]). Compared with patients in the lowest nHR quartile (<57 beats/min) group, patients in the highest quartile group (>65 beats/min) had an increased risk of nonarrhythmic death (adjusted hazard ratio [AHR] 2.25; 95% confidence interval [CI] 1.13-4.50; P = .021) and VT/VF (AHR 1.98; 95% CI 1.40-2.79; P < .001) and were characterized by the lowest level of physical activity (P < .0004 vs every other nHR quartiles). The highest 24h-HR quartile group (>75 beats/min) showed an increased risk of VT/VF (AHR 2.13; 95% CI 1.52-2.99; P < .001) and a weaker though significant asso-ciation with nonarrhythmic mortality (AHR 1.80; 95% CI 1.00-3.22; P = .05) as compared with the lowest 24h-HR quartile group (<65 beats/min).CONCLUSION In remotely monitored patients with implantable cardioverter-defibrillator/CRT-D on 0-blocker therapy for heart fail-ure, elevated heart rates (nHR >65 beats/min and 24h-HR >75 beats/min) were associated with increased mortality and VT/VF risk. nHR showed a stronger association than 24h-HR with worst prognosis and lowest physical activity.

Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction

Calvi, Valeria;
2022-01-01

Abstract

BACKGROUND Elevated resting heart rate is a risk factor for cardio-vascular events.OBJECTIVE The purpose of this study was to investigate the clinical significance of nocturnal heart rate (nHR) and 24-hour mean heart rate (24h-HR) obtained by continuous remote monitoring (RM) of implantable devices.METHODS We analyzed daily-sampled trends of nHR, 24h-HR, and physical activity in patients on b-blocker therapy for chronic heart failure and with implantable cardioverter-defibrillators or cardiac resynchronization therapy defibrillators (CRT-Ds). Patients were grouped by average nHR and 24h-HR quartile during follow-up to es-timate the respective incidence of nonarrhythmic death and device -treated ventricular tachycardia/fibrillation (VT/VF).RESULTS The study cohort included 1330 patients (median age 69 years [interquartile range 61-77 years]; 41% [n = 550] with CRT-D; median follow-up 25 months [interquartile range 13-42 months]). Compared with patients in the lowest nHR quartile (<57 beats/min) group, patients in the highest quartile group (>65 beats/min) had an increased risk of nonarrhythmic death (adjusted hazard ratio [AHR] 2.25; 95% confidence interval [CI] 1.13-4.50; P = .021) and VT/VF (AHR 1.98; 95% CI 1.40-2.79; P < .001) and were characterized by the lowest level of physical activity (P < .0004 vs every other nHR quartiles). The highest 24h-HR quartile group (>75 beats/min) showed an increased risk of VT/VF (AHR 2.13; 95% CI 1.52-2.99; P < .001) and a weaker though significant asso-ciation with nonarrhythmic mortality (AHR 1.80; 95% CI 1.00-3.22; P = .05) as compared with the lowest 24h-HR quartile group (<65 beats/min).CONCLUSION In remotely monitored patients with implantable cardioverter-defibrillator/CRT-D on 0-blocker therapy for heart fail-ure, elevated heart rates (nHR >65 beats/min and 24h-HR >75 beats/min) were associated with increased mortality and VT/VF risk. nHR showed a stronger association than 24h-HR with worst prognosis and lowest physical activity.
2022
Heart failure
Heart rate
Implantable cardioverter-defibrillator
Remote monitoring
Ventricular arrhythmia
β-Blockers
File in questo prodotto:
File Dimensione Formato  
Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction HEART RYTHM 2022.pdf

solo gestori archivio

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 5.04 MB
Formato Adobe PDF
5.04 MB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/581993
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact